March 25, 2025 - 17:04

Officials with Columbia River Mental Health Services have announced the furlough of several employees and the suspension of critical services for thousands of patients in Clark County due to severe financial constraints. The organization, which provides essential mental health support, has found itself in a precarious situation, leading to significant disruptions in care for those relying on their services.
The decision to pause operations comes amid ongoing budgetary challenges that have left the organization without sufficient funds to maintain its current level of service. Community leaders and mental health advocates are expressing deep concern over the impact of these cuts, particularly as mental health needs continue to rise in the wake of the ongoing public health crisis.
Patients who depend on these vital services are now left in uncertainty, with many expressing feelings of frustration and anxiety about their care. The organization is actively seeking solutions to restore funding and resume services, emphasizing the importance of mental health support in the community.
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...